These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 32410255)

  • 1. Prophylactic thoracic duct ligation is associated with poor prognosis and regional lymph node relapse in esophageal squamous cell carcinoma.
    Chen JY; Liu QW; Zhang SS; Li JB; Yang H; Wen J; Fu JH
    J Surg Oncol; 2020 Aug; 122(2):336-343. PubMed ID: 32410255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic thoracic duct ligation has unfavorable impact on overall survival in patients with resectable oesophageal cancer.
    Hou X; Fu JH; Wang X; Zhang LJ; Liu QW; Luo KJ; Lin P; Yang HX
    Eur J Surg Oncol; 2014 Dec; 40(12):1756-62. PubMed ID: 24913091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial.
    Li B; Hu H; Zhang Y; Zhang J; Miao L; Ma L; Luo X; Zhang Y; Ye T; Li H; Zhou J; Li Y; Shen L; Zhao K; Fan M; Zhu Z; Wang J; Xu J; Deng Y; Lu Q; Jia H; Cheng X; Li H; Zhang Y; Li C; Pan Y; Liu S; Hu H; Shao L; Sun Y; Xiang J; Chen H
    Ann Surg; 2018 May; 267(5):826-832. PubMed ID: 28448385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Cervical Lymph Node Dissection in Thoracoscopic Esophagectomy for Esophageal Cancer Increases Postoperative Complications and Does Not Improve Survival.
    Koterazawa Y; Oshikiri T; Takiguchi G; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Fujino Y; Tominaga M; Suzuki S; Kakeji Y
    Ann Surg Oncol; 2019 Sep; 26(9):2899-2904. PubMed ID: 31187365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally invasive oesophagectomy with extended lymph node dissection and thoracic duct resection for early-stage oesophageal squamous cell carcinoma.
    Matsuda S; Kawakubo H; Takeuchi H; Hayashi M; Mayanagi S; Takemura R; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
    Br J Surg; 2020 May; 107(6):705-711. PubMed ID: 32077101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and management of chylothorax after Ivor Lewis esophagectomy for cancer of the esophagus.
    Brinkmann S; Schroeder W; Junggeburth K; Gutschow CA; Bludau M; Hoelscher AH; Leers JM
    J Thorac Cardiovasc Surg; 2016 May; 151(5):1398-404. PubMed ID: 26936011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters.
    Anand S; Kalayarasan R; Chandrasekar S; Gnanasekaran S; Pottakkat B
    J Gastrointest Cancer; 2019 Jun; 50(2):230-235. PubMed ID: 29344808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracic Duct Resection During Esophagectomy Does Not Contribute to Improved Prognosis in Esophageal Squamous Cell Carcinoma: A Propensity Score Matched-Cohort Study.
    Oshikiri T; Takiguchi G; Miura S; Goto H; Otsubo D; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Nakamura T; Suzuki S; Kakeji Y
    Ann Surg Oncol; 2019 Nov; 26(12):4053-4061. PubMed ID: 31313045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
    Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term outcomes of prophylactic thoracic duct ligation during thoracoscopic-laparoscopic McKeown esophagectomy for cancer: a propensity score matching analysis.
    Bao T; Wang YJ; Li KK; Liu XH; Guo W
    Surg Endosc; 2020 Nov; 34(11):5023-5029. PubMed ID: 31828499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic patterns of subcarinal, right and left recurrent laryngeal nerve lymph nodes in thoracic esophageal squamous cell carcinoma without neoadjuvant therapy.
    Ye G; Pan G; Zhu X; Li N; Liu H; Geng G; Jiang J
    J Cancer Res Clin Oncol; 2024 Aug; 150(8):387. PubMed ID: 39110234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy comparison between two-field and three-field lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lin D; Ye T; Ma L; Shao L; Song Z; Jiang S; Xiang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):990-994. PubMed ID: 27680065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluating prophylactic ligation of thoracic duct during radical resection of esophageal carcinoma].
    Fu JH; Hu Y; Huang WZ; Yang H; Zhu ZH; Zheng B
    Ai Zheng; 2006 Jun; 25(6):728-30. PubMed ID: 16764769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Ivor-Lewis versus Sweet procedure for middle and lower thoracic esophageal squamous cell carcinoma: A STROBE compliant study.
    Wang J; Wei N; Jiang N; Lu Y; Zhang X
    Medicine (Baltimore); 2019 Feb; 98(6):e14416. PubMed ID: 30732195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of metastasis from superficial squamous cell carcinoma of the thoracic esophagus.
    Miyata H; Sugimura K; Motoori M; Omori T; Yamamoto K; Yanagimoto Y; Shinno N; Yasui M; Takahashi H; Wada H; Ohue M; Yano M
    Surgery; 2019 Dec; 166(6):1033-1040. PubMed ID: 31493901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of short- and long-term outcomes between 3-field and modern 2-field lymph node dissections for thoracic oesophageal squamous cell carcinoma: a propensity score matching analysis.
    Fan N; Yang H; Zheng J; Chen D; Wang W; Tan Z; Huang Y; Lin P
    Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):434-441. PubMed ID: 31135037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletonizing En Bloc Esophagectomy Revisited: Oncologic Outcome in Association with the Presence of Thoracic Duct Lymph Nodes.
    Kim HE; Yang YH; Park BJ; Park SY; Min IK; Kim DJ
    Ann Surg Oncol; 2022 Aug; 29(8):4909-4917. PubMed ID: 35438467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate location describe and management of lymph node recurrence after esophagectomy for thoracic esophageal squamous cell carcinoma: a retrospective cohort study.
    Zhao Q; Sun J; Zheng F; Dan Han ; Fu C; Sun H; Liu C; Wang Z; Huang W; Wang R; Li B
    Int J Surg; 2024 Jun; 110(6):3440-3449. PubMed ID: 38498405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of prophylactic thoracic duct ligation during esophagectomy on the incidence of chylothorax and survival of the patients: an updated review.
    Liu L; Gong L; Zhang M; Wu W
    Postgrad Med; 2021 Apr; 133(3):265-271. PubMed ID: 32729759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct.
    Matsuda S; Takeuchi H; Kawakubo H; Shimada A; Fukuda K; Nakamura R; Takahashi T; Wada N; Kameyama K; Kitagawa Y
    Medicine (Baltimore); 2016 Jun; 95(24):e3839. PubMed ID: 27310961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.